Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1200
+0.0100 (9.09%)
Aug 28, 2026, 2:15 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 16.37 million as of August 28, 2026. Its market cap has decreased by -29.58% in one year.
Market Cap
16.37M
Enterprise Value
22.17M
Revenue
2.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 16.37M, a decrease of -74.32%. That is a compound annual growth rate of -16.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 16.37M | -7.24% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onco-Innovations | 34.16M |
| Resverlogix | 32.71M |
| Lobe Sciences | 28.30M |
| Sharp Therapeutics | 27.37M |
| Devonian Health Group | 27.11M |
| Pharmala Biotech Holdings | 25.12M |
| Alzai Health | 24.06M |
| Hemostemix | 15.83M |